Highlights Uni-Bio Science Group Limited

Equities

690 KYG9198H1406

Market Closed - Hong Kong S.E. Other stock markets 04:09:00 2024-05-03 am EDT			5-day change	1st Jan Change
0.084 ^HKD	-1.18%		-1.18%	+16.67%

Mar. 27	Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 14	Uni-Bio Science's Profit to Climb in 2023	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Uni-Bio Science's Profit to Climb in 2023	Feb. 14	MT
Uni-Bio Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023	Feb. 13	CI
Chinese Regulator NMPA Accepts Uni-Bio's Marketing Application for Eye Drops	Jan. 23	MT
Uni-Bio Science Group Limited Announces the Acceptance of its Marketing Application for Diquafosol Sodium Eye Drops by the China National Medical Products Administration	Jan. 23	CI
Uni-Bio Science Group Limited Announces Approval of Marketing Application of Bogutai (Teriparatide Injection) by the China National Medical Products Administration	Jan. 21	CI
Uni-Bio Science Group Limited commences an Equity Buyback for 636,476,815 shares, representing 10% of its issued share capital, under the authorization approved on May 19, 2023.	Dec. 13	CI
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Uni-Bio Science Group Limited Provides Financial Guidance for the Year Ended 31 December 2022	23-03-06	CI
Uni-Bio Science Unit Renews Property Lease for Two Years	22-12-23	MT
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Uni-Bio Science Group Limited Announces Marketing Application of Bogutai (Teriparatide Injection) Officially Accepted by the China National Medical Products Administration	22-06-28	CI
Uni-Bio Science CFO Resigns	22-04-01	MT
Uni-Bio Science Narrows Loss on Higher Core Drugs Sales in 2021; Shares Rise 3%	22-03-22	MT
Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21	CI
Uni-Bio Science Arm Signs R&D Deal for Medical Aesthetics Materials Development	22-01-05	MT
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Uni-Bio Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2021	21-08-11	CI
Uni-Bio Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021	21-08-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Uni-Bio Science Group Limited

Equities

690

KYG9198H1406

Highlights

Filters